Browse by author
Lookup NU author(s): Dr Iain McKinnonORCiD
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Background: Vitamin D deficiency is common among people withIntellectual and Developmental Disability (IDD) and is linked to worsehealth outcomes.Aims: To re-evaluate vitamin D testing and supplementation amonginpatients with IDD and examine any correlates with physical healthconditions including COVID-19.Method: Records of all inpatients between January 2019 and July 2020 were examined for 25-hydroxyvitamin D [25(OH)D] level, ward area, supplementation status, test seasonality, medication, and health status.Results: Mean 25(OH)D level for supplemented (800IU/day) patients was 75nmol/l (SD 20) compared to 40nmol/l (SD 19) in the nonsupplemented group (p<0.001). Thirty-eight percent of those who were inpatients during the first wave of the COVID-19 pandemic developed symptoms, but the small sample size could not establish vitamin D levels as a predictor of outcome.Conclusions: Vitamin D (800IU/day) supplementation is effective butadequacy of the nationally recommended dose of 400IU/day is unclear. Links to COVID-19 merit further research.
Author(s): Dudley B, Ostrowski M, Ciausu V, Ince C, McKinnon I
Publication type: Article
Publication status: Published
Journal: BJPsych Bulletin
Pages: epub ahead of print
Online publication date: 18/05/2021
Acceptance date: 15/04/2021
Date deposited: 18/05/2021
ISSN (print): 2056-4708
ISSN (electronic): 2056-4694
Publisher: Cambridge University Press
Altmetrics provided by Altmetric